Clinical correlations of the 3q21;q26 cytogenetic anomaly. A leukemic or myelodysplastic syndrome with preserved or increased platelet production and lack of response to cytotoxic drug therapy

Cancer. 1985 Feb 1;55(3):535-41. doi: 10.1002/1097-0142(19850201)55:3<535::aid-cncr2820550311>3.0.co;2-4.

Abstract

Three patients presenting with acute leukemic disorder and chromosome 3 rearrangement involving bands q21;q26 are reported, and the literature on chromosome 3q abnormalities is reviewed. All reported patients carrying a paracentric 3q inversion or a translocation 3;3 with breakpoints in q21;q26 had a myelodysplastic or acute leukemic disorder with a normal or elevated platelet count and lack of response to cytotoxic drug therapy. They showed an associated incidence of -7 or 7q- anomalies higher than de novo acute leukemia and appear to constitute a definite subgroup of the leukemic disorders with very poor prognosis. The majority of patients showing other chromosome 3 long arm rearrangements showed evidence of leukemic process, were in blastic crisis, or had been exposed to chemotherapy, exhibiting also a higher incidence of associated -5 or -7 cytogenetic abnormalities than is observed in patients not exposed to toxic agents.

Publication types

  • Case Reports
  • Comparative Study

MeSH terms

  • Acute Disease
  • Adult
  • Bone Marrow / ultrastructure
  • Chromosome Aberrations*
  • Chromosome Banding
  • Chromosomes, Human, 1-3 / ultrastructure*
  • Female
  • Humans
  • Leukemia / drug therapy
  • Leukemia / genetics*
  • Leukemia / pathology
  • Male
  • Middle Aged
  • Myeloproliferative Disorders / genetics*
  • Myeloproliferative Disorders / pathology
  • Translocation, Genetic